References
- Garg S , SerruysPW . Coronary stents: current status . J. Am. Coll. Cardiol.56 ( 10 Suppl. ), S1 – S42 ( 2010 ).
- Montone RA , SabatoV, SguegliaGA, NiccoliG . Inflammatory mechanisms of adverse reactions to drug-eluting stents . Curr. Vasc. Pharmacol.11 ( 4 ), 392 – 398 ( 2013 ).
- Niccoli G , MontoneRA, FerranteG, CreaF . The evolving role of inflammatory biomarkers in risk assessment after stent implantation . J. Am. Coll. Cardiol.56 ( 22 ), 1783 – 1793 ( 2010 ).
- Montone RA , FerranteG, BacàM, NiccoliG . Predictive value of C-reactive protein after drug-eluting stent implantation . Future Cardiol.6 ( 2 ), 167 – 179 ( 2010 ).
- Niccoli G , SchiavinoD, BelloniFet al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents . Eur. Heart J.30 ( 11 ), 1340 – 1347 ( 2009 ).
- Park DW , YunSC, LeeJYet al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation . Circulation120 ( 20 ), 1987 – 1995 ( 2009 ).
- Park DW , LeeSW, YunSCet al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation . J. Am. Coll. Cardiol.58 ( 25 ), 2630 – 2639 ( 2011 ).
- Oemrawsingh RM , ChengJM, AkkerhuisKMet al. High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention . EuroIntervention12 ( 3 ), 345 – 351 ( 2016 ).
- Schoos MM , KelbækH, KofoedKFet al. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention . Am. J. Cardiol.107 ( 11 ), 1597 – 1603 ( 2011 ).
- Niccoli G , SguegliaGA, LatibA, CreaF, ColomboA . CACTUS Study Group . Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis . Catheter. Cardiovasc. Interv.83 ( 1 ), E37 – E44 ( 2014 ).
- Niccoli G , ConteM, CosentinoNet al. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation . J. Invasive Cardiol.23 ( 1 ), 16 – 20 ( 2011 ).
- Shiba M , ItayaH, IijimaR, NakamuraM . Influence of late vascular inflammation on long-term outcomes among patients undergoing implantation of drug eluting stents: role of c-reactive protein . J. Am. Heart Assoc.5 ( 9 ), e003354 ( 2016 ).
- Hsieh IC , ChenCC, HsiehMJet al. Prognostic impact of 9-month high-sensitivity c-reactive protein levels on long-term clinical outcomes and in-stent restenosis in patients at 9 months after drug-eluting stent implantation . PLoS ONE10 ( 9 ), e0138512 ( 2015 ).
- Kang WC , Il MoonC, LeeKet al. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation . Coron. Artery Dis.22 ( 8 ), 526 – 532 ( 2011 ).
- Lee SY , HongMK, MintzGSet al. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis . Int. J. Cardiovasc. Imaging30 ( 6 ), 1003 – 1311 ( 2014 ).
- Montone RA , NiccoliG, De MarcoFet al. Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: a meta-analysis of randomized controlled trials . Circulation135 ( 22 ), 2145 – 2154 ( 2017 ).